Handelsbanken Fonder’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-5,779
| Closed | -$1.42M | – | 1633 |
|
|
2022
Q3 | $1.42M | Buy |
5,779
+318
| +6% | +$78.1K | 0.01% | 574 |
|
|
2022
Q2 | $1.35M | Sell |
5,461
-4,129
| -43% | -$1.02M | 0.01% | 604 |
|
|
2022
Q1 | $3.18M | Sell |
9,590
-848
| -8% | -$281K | 0.02% | 519 |
|
|
2021
Q4 | $3.75M | Sell |
10,438
-837
| -7% | -$301K | 0.02% | 518 |
|
|
2021
Q3 | $3.67M | Buy |
11,275
+21
| +0.2% | +$6.84K | 0.02% | 522 |
|
|
2021
Q2 | $3.51M | Sell |
11,254
-273
| -2% | -$85.2K | 0.02% | 535 |
|
|
2021
Q1 | $3.67M | Buy |
11,527
+548
| +5% | +$175K | 0.02% | 502 |
|
|
2020
Q4 | $3.56M | Buy |
10,979
+702
| +7% | +$228K | 0.02% | 488 |
|
|
2020
Q3 | $2.85M | Buy |
10,277
+700
| +7% | +$194K | 0.02% | 481 |
|
|
2020
Q2 | $2.31M | Buy |
+9,577
| New | +$2.31M | 0.02% | 491 |
|
|
2019
Q3 | – | Sell |
-25,500
| Closed | -$6.64M | – | 195 |
|
|
2019
Q2 | $6.64M | Sell |
25,500
-6,000
| -19% | -$1.56M | 0.12% | 154 |
|
|
2019
Q1 | $9M | Buy |
31,500
+13,000
| +70% | +$3.71M | 0.17% | 131 |
|
|
2018
Q4 | $6.01M | Buy |
18,500
+2,000
| +12% | +$650K | 0.12% | 138 |
|
|
2018
Q3 | $7.42M | Buy |
16,500
+7,000
| +74% | +$3.15M | 0.14% | 139 |
|
|
2018
Q2 | $3.89M | Sell |
9,500
-8,000
| -46% | -$3.27M | 0.08% | 155 |
|
|
2018
Q1 | $5.09M | Sell |
17,500
-2,500
| -13% | -$727K | 0.1% | 149 |
|
|
2017
Q4 | $3.75M | Hold |
20,000
| – | – | 0.08% | 146 |
|
|
2017
Q3 | $3.37M | Buy |
20,000
+12,000
| +150% | +$2.02M | 0.08% | 148 |
|
|
2017
Q2 | $1.15M | Buy |
+8,000
| New | +$1.15M | 0.03% | 157 |
|